Evolent Health (NYSE:EVH) Issues Earnings Results

Evolent Health (NYSE:EVH) released its earnings results on Thursday. The technology company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.35), Zacks reports. Evolent Health had a negative net margin of 2.93% and a positive return on equity of 6.30%.

Evolent Health Price Performance

Shares of Evolent Health stock traded up $0.19 during midday trading on Thursday, hitting $10.71. 2,623,019 shares of the company were exchanged, compared to its average volume of 2,149,710. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.04 and a quick ratio of 1.04. The firm has a market cap of $1.25 billion, a P/E ratio of -11.77 and a beta of 1.45. Evolent Health has a 52 week low of $9.45 and a 52 week high of $35.00. The firm has a 50 day simple moving average of $10.79 and a 200-day simple moving average of $18.98.

Wall Street Analyst Weigh In

EVH has been the topic of a number of research analyst reports. Canaccord Genuity Group lowered their target price on Evolent Health from $23.00 to $16.00 and set a “buy” rating on the stock in a report on Thursday, January 23rd. Stephens lowered their target price on Evolent Health from $16.00 to $12.00 and set an “equal weight” rating on the stock in a report on Tuesday, January 21st. Truist Financial reduced their price objective on Evolent Health from $20.00 to $15.00 and set a “buy” rating for the company in a research report on Wednesday, January 22nd. Royal Bank of Canada reduced their price objective on Evolent Health from $20.00 to $17.00 and set an “outperform” rating for the company in a research report on Tuesday, January 14th. Finally, UBS Group reduced their price objective on Evolent Health from $27.00 to $14.00 and set a “buy” rating for the company in a research report on Thursday, January 16th. One research analyst has rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $17.92.

About Evolent Health

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.